SPONSOR
Institut Curie
Total Trials
6
Recruiting
6
Phases
Phase 3, Phase 2
Conditions studied: CancerTriple Negative Breast CancerBreast CarcinomaHER2-positive Breast CancerOvarian CancerTriple-Negative Breast CancerHead and Neck CancerCervical CancerSarcomaVulva Cancer
Institut Curie is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Cancer, Triple Negative Breast Cancer, Breast Carcinoma, HER2-positive Breast Cancer.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Curie
How many clinical trials has Institut Curie sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Institut Curie, of which 6 are actively recruiting participants. These trials cover conditions including Cancer, Triple Negative Breast Cancer, Breast Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Curie research focus on?
Institut Curie clinical trials span Cancer, Triple Negative Breast Cancer, Breast Carcinoma, HER2-positive Breast Cancer, Ovarian Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Curie clinical trial?
To participate in a Institut Curie trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Curie trials with current recruitment status updated daily.
Clinical Trials by Institut Curie
NCT05558644
Recruiting
Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)
Cancer
NCT06225505
Recruiting
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Triple Negative Breast Cancer
NCT06195709 Phase 3
Recruiting
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
Breast Carcinoma
NCT05955170 Phase 2
Recruiting
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
HER2-positive Breast Cancer
NCT03017573
Recruiting
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Ovarian Cancer
NCT05088395
Recruiting
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology